BrainAurora Medical Technology Company Description

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China.

The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies.

The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children.

It also develops covid-19 induced cognitive impairment assessment and recovery training software; ADHD assessment and treatment software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions.

In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.

BrainAurora Medical Technology Limited

Country	Cayman Islands
Founded	2012
Industry	Health Information Services
Sector	Healthcare
Employees	159
CEO	Longjun Cai

Contact Details

Address: Room 1301, Building 3 Shaoxing China
Phone	86 10 6296 5575
Website	66nao.cn

Stock Details

Ticker Symbol	6681
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	KYG1300R1083
SIC Code	7372

Key Executives

Name	Position
Longjun Cai	Chief Executive Officer, Chief Technology Officer, Chief Operating Officer and Chief Research Officer
Zheng Tan	Chief Strategy Officer and Chairman
Junjie Wang	Chief Financial Officer and Joint Company Secretary
Zhiyuan Lai	Vice President of Market and Operation
Ying Man Sham	Joint Company Secretary